|
Aug 12
|
RGEN Q2 Deep Dive: Chromatography and Filtration Drive Growth, Guidance Lifted Amid New Modalities Uncertainty
|
|
Aug 12
|
5 Must-Read Analyst Questions From Repligen’s Q2 Earnings Call
|
|
Aug 10
|
Repligen Second Quarter 2025 Earnings: Beats Expectations
|
|
Aug 7
|
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
|
|
Aug 4
|
Is Now An Opportune Moment To Examine Repligen Corporation (NASDAQ:RGEN)?
|
|
Jul 31
|
Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
|
|
Jul 29
|
Why Repligen (RGEN) Stock Is Up Today
|
|
Jul 29
|
Repligen (RGEN) Lags Q2 Earnings Estimates
|
|
Jul 29
|
Repligen’s (NASDAQ:RGEN) Q2 Sales Top Estimates, Full-Year Sales Guidance is Optimistic
|
|
Jul 29
|
Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
|
|
Jul 28
|
Repligen (RGEN) Reports Q2: Everything You Need To Know Ahead Of Earnings
|
|
Jul 22
|
Netflix downgraded, Intel initiated: Wall Street's top analyst calls
|
|
Jul 21
|
Here's Why Repligen (RGEN) is a Strong Growth Stock
|
|
Jul 18
|
Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know
|
|
Jul 18
|
3 Reasons RGEN is Risky and 1 Stock to Buy Instead
|
|
Jul 17
|
Repligen to Report Second Quarter 2025 Financial Results
|
|
Jul 7
|
Repligen And 2 Other Stocks That May Be Trading Below Estimated Value
|
|
Jun 24
|
5 Insightful Analyst Questions From Repligen’s Q1 Earnings Call
|
|
May 27
|
Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report
|
|
May 22
|
Repligen Corporation to Present at William Blair Growth Conference
|